243 related articles for article (PubMed ID: 17085798)
1. beta2-Agonists at the Olympic Games.
Fitch KD
Clin Rev Allergy Immunol; 2006; 31(2-3):259-68. PubMed ID: 17085798
[TBL] [Abstract][Full Text] [Related]
2. Asthma medication in Finnish olympic athletes: no signs of inhaled beta2-agonist overuse.
Alaranta A; Alaranta H; Palmu P; Alha P; Pietilä K; Heliövaara M; Helenius I
Med Sci Sports Exerc; 2004 Jun; 36(6):919-24. PubMed ID: 15179158
[TBL] [Abstract][Full Text] [Related]
3. Impact of changes in the IOC-MC asthma criteria: a British perspective.
Dickinson JW; Whyte GP; McConnell AK; Harries MG
Thorax; 2005 Aug; 60(8):629-32. PubMed ID: 16061702
[TBL] [Abstract][Full Text] [Related]
4. The asthmatic athlete, inhaled beta agonists, and performance.
McKenzie DC; Stewart IB; Fitch KD
Clin J Sport Med; 2002 Jul; 12(4):225-8. PubMed ID: 12131055
[TBL] [Abstract][Full Text] [Related]
5. Treatment of exercise-induced asthma, respiratory and allergic disorders in sports and the relationship to doping: Part II of the report from the Joint Task Force of European Respiratory Society (ERS) and European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA(2)LEN.
Carlsen KH; Anderson SD; Bjermer L; Bonini S; Brusasco V; Canonica W; Cummiskey J; Delgado L; Del Giacco SR; Drobnic F; Haahtela T; Larsson K; Palange P; Popov T; van Cauwenberge P; ; ;
Allergy; 2008 May; 63(5):492-505. PubMed ID: 18394123
[TBL] [Abstract][Full Text] [Related]
6. Bronchial challenges in athletes applying to inhale a beta2-agonist at the 2004 Summer Olympics.
Anderson SD; Sue-Chu M; Perry CP; Gratziou C; Kippelen P; McKenzie DC; Beck KC; Fitch KD
J Allergy Clin Immunol; 2006 Apr; 117(4):767-73. PubMed ID: 16630932
[TBL] [Abstract][Full Text] [Related]
7. Discrimination of prohibited oral use of salbutamol from authorized inhaled asthma treatment.
Bergés R; Segura J; Ventura R; Fitch KD; Morton AR; Farré M; Mas M; de La Torre X
Clin Chem; 2000 Sep; 46(9):1365-75. PubMed ID: 10973867
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic use exemptions (TUEs) at the Olympic Games 1992-2012.
Fitch KD
Br J Sports Med; 2013 Sep; 47(13):815-8. PubMed ID: 23591601
[TBL] [Abstract][Full Text] [Related]
9. Asthma and the elite athlete: summary of the International Olympic Committee's consensus conference, Lausanne, Switzerland, January 22-24, 2008.
Fitch KD; Sue-Chu M; Anderson SD; Boulet LP; Hancox RJ; McKenzie DC; Backer V; Rundell KW; Alonso JM; Kippelen P; Cummiskey JM; Garnier A; Ljungqvist A
J Allergy Clin Immunol; 2008 Aug; 122(2):254-60, 260.e1-7. PubMed ID: 18678340
[TBL] [Abstract][Full Text] [Related]
10. Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes?
Kindermann W
Sports Med; 2007; 37(2):95-102. PubMed ID: 17241101
[TBL] [Abstract][Full Text] [Related]
11. Ergogenic effects of inhaled beta2-agonists in non-asthmatic athletes.
Wolfarth B; Wuestenfeld JC; Kindermann W
Endocrinol Metab Clin North Am; 2010 Mar; 39(1):75-87, ix. PubMed ID: 20122451
[TBL] [Abstract][Full Text] [Related]
12. An overview of asthma and airway hyper-responsiveness in Olympic athletes.
Fitch KD
Br J Sports Med; 2012 May; 46(6):413-6. PubMed ID: 22228581
[TBL] [Abstract][Full Text] [Related]
13. Inhaled beta2 agonists and performance in competitive athletes.
Kindermann W; Meyer T
Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i43-7. PubMed ID: 16799103
[TBL] [Abstract][Full Text] [Related]
14. The asthmatic athlete: inhaled Beta-2 agonists, sport performance, and doping.
McKenzie DC; Fitch KD
Clin J Sport Med; 2011 Jan; 21(1):46-50. PubMed ID: 21200170
[TBL] [Abstract][Full Text] [Related]
15. Pharmaceutical treatment of asthma symptoms in elite athletes - doping or therapy?
Backer V; Lund T; Pedersen L
Scand J Med Sci Sports; 2007 Dec; 17(6):615-22. PubMed ID: 18093034
[TBL] [Abstract][Full Text] [Related]
16. Asthma in elite athletes.
Elers J; Pedersen L; Backer V
Expert Rev Respir Med; 2011 Jun; 5(3):343-51. PubMed ID: 21702657
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetic profile of inhaled and oral salbutamol in elite athletes with asthma and nonasthmatic subjects.
Elers J; Pedersen L; Henninge J; Hemmersbach P; Dalhoff K; Backer V
Clin J Sport Med; 2012 Mar; 22(2):140-5. PubMed ID: 22388343
[TBL] [Abstract][Full Text] [Related]
18. Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes.
Carlsen KH; Hem E; Stensrud T; Held T; Herland K; Mowinckel P
Respir Med; 2001 Jul; 95(7):571-6. PubMed ID: 11453313
[TBL] [Abstract][Full Text] [Related]
19. Responses to bronchial challenge submitted for approval to use inhaled beta2-agonists before an event at the 2002 Winter Olympics.
Anderson SD; Fitch K; Perry CP; Sue-Chu M; Crapo R; McKenzie D; Magnussen H
J Allergy Clin Immunol; 2003 Jan; 111(1):45-50. PubMed ID: 12532095
[TBL] [Abstract][Full Text] [Related]
20. High-dose inhaled salbutamol has no acute effects on aerobic capacity or oxygen uptake kinetics in healthy trained men.
Elers J; Mørkeberg J; Jansen T; Belhage B; Backer V
Scand J Med Sci Sports; 2012 Apr; 22(2):232-9. PubMed ID: 21083771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
